Reproductive Medicine Associates of New York continues to be globally recognized as one of the world’s leading IVF centers with delivery rates surpassing the national average for over a decade. By utilizing the most advanced technologies at our state-of-the art facilities, such as blastocyst culture, and preimplantation genetic screening (PGS) / preimplantation genetic diagnosis (PGD), our expert team of physicians and embryologists has successfully facilitated the births of thousands of healthy babies, and we are proud to share our results as reported by the Society for Assisted Reproductive Technology (SART) www.sart.org.
Note: RMA of New York has achieved successful pregnancies for patients through the age of 46, and accepts appropriate patients with poor prognosis, including those with a history of IVF failure at other centers.
Now with single embryo transfer using comprehensive chromosomal screening (CCS), we are able to achieve a live birth in a shorter period of time.
We are also experiencing a high rate of singleton pregnancies with a low occurrence of high-order multiples:
RMA of New York reports its success rates annually to both the Society for Assisted Reproductive Technology (SART), a professional organization dedicated to maintaining the integrity of the practice of reproductive medicine in the United States, and the Center for Disease Control and Prevention (CDC). In order to assure that success rate calculations most accurately reflect center experience, SART has specific guidelines to be followed when publicizing success rates. RMA of New York is in full compliance with these guidelines.
The graph above reflects live birth outcomes for women who have undergone an embryo transfer, respective of age group, between January 1, 2014 and December 31, 2014.
Important note: A comparison of clinic success rates may not be meaningful because patient medical characteristics, treatment approaches and entrance criteria for ART may vary from clinic to clinic. When viewing data from any clinic, if a specific data point comprises fewer than 20 cycles, then the numerator and denominator must be reported; if the data point comprises 20 or more cycles, then the denominator (number of cycles) and the % success may be reported as the numerator is calculable.
Why is 2014 the most recent data available?
Clinics must wait until they receive notification of every single birth from the reporting year before they can submit all data; this means that for 2014, clinics had to wait until at least September of 2015 to compile all live birth data. Once the data is submitted, checked and verified for accuracy, it can then be published on the SART website or CDC website.
New York Magazine Recognizes Five Reproductive Medicine Associates of New York Physicians in their 2017 “Best Doctors” Issue Read full article here. Click here to read the press release. ...READ MORE
Single vs. Multiple Embryo Transfer By: Matthew A. Lederman, MD In vitro fertilization (IVF) has evolved dramatically over the last few decades, with more than six million babies now born through assisted reproductive technology. For years, multiple embryos were transferred to the uterus in hopes ...READ MORE
An Exclusive Screening of “Vegas Baby” with Pregnantish and Dr Joseph Davis of RMA of New York Mon, June 26, 2017 7:00 PM – 10:00 PM EDT ...READ MORE
to receive all the latest News, Events & MORE!